三级aa视频在线观看-三级国产-三级国产精品一区二区-三级国产三级在线-三级国产在线

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Innovation

Scientists to test medicine for bone loss on Tianzhou-1

Xinhua | Updated: 2017-04-21 15:40
Share
Share - WeChat
BEIJING - Scientists will test a medicine to treat bone loss during the maiden voyage of China's first cargo spacecraft Tianzhou-1. The medicine has been specially developed for astronauts, but they hope it will benefit ordinary people too.

The main mission of Tianzhou-1 launched on Thursday is to test propellant refueling technology, which is crucial for the construction and operation of China's planned space station. But each voyage is a precious opportunity to conduct space experiments.

Chinese scientists will use the micro-gravity environment to test the effect of 3-hydroxybutyric acid (3HB) in preventing osteoporosis, said research leader Chen Guoqiang ,who is also director of the Center for Synthetic and Systems Biology at Tsinghua University.

Normally, the solid structure of bone tissue is stimulated and maintained by gravity and physical exercise. But the micro-gravity environment in space eases the load on bones, causing rapid bone loss and osteoporosis, Chen said.

"One day of bone loss in space is equivalent to a year on earth," he said.

Research shows astronauts suffer average monthly bone loss of 0.5 percent to 2 percent in space, especially in weight-bearing bones such as the tibia, femur and vertebrae.

Back on earth, they can take double or triple the time of their flight period to recover. Sometimes bone loss is permanent.

Micro-gravity mainly inhibits the differentiation of osteoblasts (bone-forming cells), which is accompanied by the mass growth of osteoclasts (bone-resorbing cells), causing bone structure to change, said Chen.

Standard drug treatments for osteoporosis have a range of side effects, including tumors or cardiovascular diseases. The medicines are also relatively ineffective for treating osteoporosis caused by micro-gravity.

Chen said 3HB is one of the main components of ketone bodies, which occur naturally in mammals. It had been used to treat epilepsy for many years.

"We found that 3HB can promote bone formation," said Chen.

In an experiment simulating the micro-gravity environment, the effect was obvious.

Unlike the chemical synthetic 3HB for treating epilepsy, Chen's team use microbial fermentation to produce 3HB, which has entirely the same structure as the 3HB naturally existing in the human body. So it's safer than chemical synthetic drugs, Chen said.

Experiments simulating the micro-gravity environment have been conducted on the ground. Scientists hung up mice by their hind legs, and found that those given 3HB had normal bones, while those without suffered serious bone loss.

"We hope to test the effect of the medicine in a real space micro-gravity environment," Chen said.

Since Tianzhou-1 cannot carry animals, scientists will compare the osteoblast cell samples treated and not treated with 3HB. Microscope images of the samples will be transmitted to earth.
Although China has conducted many experiments on the Shenzhou series spacecraft and the Tiangong-1 and Tiangong-2 space labs, opportunities for space experiments are still rare.

"After more than a decade of research we have one chance to conduct an experiment in space. We cherish the chance. We hope Chinese scientists will have more opportunities to conduct experiments in China's space station in future," Chen said.

Scientists believe the science and technologies developed in space exploration can benefit ordinary people. For instance, modern baby diapers were originally developed for astronauts on extended space walks. And the intensive care unit (ICU) system was first developed to monitor astronauts preparing to go to the moon in the 1970s.

The medicine for treating bone loss could also be used by ordinary people.

Osteoporosis is the seventh most common disease in the world. Each year it causes 8.9 million cases of fractures worldwide.

China has 90 million osteoporosis sufferers. The morbidity of osteoporosis among Chinese over 60 years old is 56 percent, while the rate among postmenopausal women is between 60 percent and 70 percent.

With China's aging population, osteoporosis cases will continue to rise. Experts estimate the number of patients in China will reach 200 million in 2050, accounting for 13.2 percent of the total population.

"We hope to solve this global problem," Chen said.
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: www.麻豆视频 | 两个人看的www视频中文字幕 | 免费观看a级片 | 亚洲国产视频一区 | 男女爱爱视频在线观看 | 小明免费 | 精品国产福利在线观看91啪 | 特级无码a级毛片特黄 | 亚洲午夜大片 | 啪啪综合 | 国产成人精品免费视频动漫 | 日本特黄特黄aaaaa大片 | 网友偷自拍原创区 | 91短视频黄色 | 非洲一级毛片又粗又长aaaa | 高潮影院 | 国产亚洲情侣久久精品 | 奇米网久久| 中国一级特黄剌激爽毛片 | 国产亚洲精品97在线观看 | 在线综合视频 | 亚洲人成一区二区不卡 | 亚洲一区二区三区高清 不卡 | 成 人 黄 色视频免费播放 | 韩国一大片a毛片女同 | 欧美日韩一区二区三区自拍 | 成人资源在线 | 一级生性活免费视频 | 黄色小片片 | 中文字幕在线视频播放 | 91精品啪在线看国产网站 | 五月激激激综合网色播免费 | 国产精品久久久久久久久齐齐 | 我想看一级黄色毛片 | 欧美一级毛片特黄黄 | 日韩高清网站 | 亚洲在线综合 | h网在线 | 91视频首页| 亚洲综合第一页 | 亚洲视频一二区 |